The first subscale of the risk perception scale was used to measure risk perception related to the experience of traveling in a PT vehicle. by Martina Gnerre (12329356)

Configuration of control site trapping webs illustrating the distribution of Rhodamine B marked captures (blue), the bait distribution zone (dashed line), and 90% (red) and 50% (gr... by James C. Beasley (392355)

Configuration of treatment site trapping webs illustrating the distribution of Rhodamine B marked captures (blue), the bait distribution zone (dashed line), and 90% (red) and 50% (... by James C. Beasley (392355)

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

HDAC1 knockdown decreases cell proliferation in the optic tectum. by Yi Tao (178829)

“…Representative immunofluorescence images of BrdU- and BLBP-labeled cells in control (D1-D4), Ctrl-MO (D5-D8), and HDAC1-MO (D9-D12) transfected brains in stage 48 tadpoles. Scale: 50 μm. (E-F). Summary data showing that HDAC1-MO transfection significantly decreased the number of BrdU- (E) and BLBP-labeled cells (F). …”

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

“…To further characterize the effects, we analyzed diurnal glycemic patterns by continuous glucose monitoring (CGM).…”

Effect of L-methionine on the frequency of persisters at different temperatures. by Elena A. Mordukhova (646403)

Basal IKK activity is decreased in cells lacking IRE1. by Arvin B. Tam (124164)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”

Lack of effects of fish oil supplementation for 12 weeks on resting metabolic rate and substrate oxidation in healthy young men: A randomized controlled trial by Sebastian Jannas-Vela (3756649)

“…RMR and substrate oxidation did not change after supplementation with OO or FO after 6 and 12 weeks. Since there was no effect of supplementation on metabolic measures, we pooled the two treatment groups to determine whether there was a seasonal effect on RMR and substrate oxidation. …”

Effect of substrate binding on hNaa50p dynamics. by Cédric Grauffel (109194)

“…C: Map of the differences of correlation between simulations of hNaa50p-MLG and hNaa50p-apo. Red dots indicate an increase in correlation, while blue dots indicate a decrease. …”

Dynamic network effects of left DLPFC-tDCS protocol (F3a-Fp2c) with a sliding window length of 50 TRs. by Yanqing Dong (8829548)

IC₅₀ is distinct for diclofenac, ibuprofen, and ASA. by Verena Leidgens (815986)

“…The assays showed a significant linear concentration-dependent decrease of cell viability, which significantly differed between (A) ibuprofen (IC₅₀, 1 mM) and (B) diclofenac (IC₅₀, 0.1 mM). …”

Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex by Dániel Horváth (4015034)

“…Inhibition of PP1 with tautomycetin increased, whereas inhibition of ROK by H1152, decreased the phosphorylation of SNAP-25 at Thr138 in B50 cells, in cortical synaptosomes, and in brain slices. …”

Signal random fluctuations. by Olga N. Milekhina (812701)

Ripple density resolution dependence on masker SPL. by Olga N. Milekhina (812701)

Ripple shift threshold dependence on masker SPL. by Olga N. Milekhina (812701)

Frequency spectra of the signal and maskers. by Olga N. Milekhina (812701)

Changes of signal parameters at ripple phase reversal as functions of the ripple density. by Olga N. Milekhina (812701)